A 59-year-old with T2D and obesity has recurrent hypoglycemia on sulfonylurea. A1c 7.1%. What change aligns with ADA 2025 to minimize hypoglycemia and...

Question

A 59-year-old with T2D and obesity has recurrent hypoglycemia on sulfonylurea. A1c 7.1%. What change aligns with ADA 2025 to minimize hypoglycemia and maintain control?

Accepted Answer

Stop sulfonylurea; start GLP-1 receptor agonist

Answer

Add basal insulin

Answer

Switch to DPP-4 inhibitor

Answer

Continue sulfonylurea and add TZD

Answer

Add alpha-glucosidase inhibitor

us-usmle-step-2 MCQ (SBA): Type 2 Diabetes Medication Selection

A 59-year-old with T2D and obesity has recurrent hypoglycemia on sulfonylurea. A1c 7.1%. What change aligns with ADA 2025 to minimize hypoglycemia and maintain control?